Location History:
- Birkerød, DK (2006)
- Hørsholm, DK (2006)
- Oberägeri, CH (2010)
Company Filing History:
Years Active: 2006-2010
Title: Innovative Advances in Therapeutic Vaccination by Søren Mouritsen
Introduction
Søren Mouritsen, an innovative inventor based in Oberägeri, Switzerland, has made significant contributions in the field of therapeutic vaccination. With a total of five patents to his name, Mouritsen's work largely focuses on inducing cell-mediated immunity against cellular antigens, specifically targeting weak antigens and self-proteins.
Latest Patents
One of Mouritsen's latest patents revolves around methods for therapeutic vaccination designed to enhance cytotoxic T-lymphocyte immunity. This method entails inducing antigen-presenting cells to present at least one CTL epitope of a weak antigen while also presenting at least one foreign T-helper lymphocyte epitope. Notably, this innovative approach can be applied to cancer-specific antigens such as PSM, Her2, and FGF8b. The technology allows for traditional polypeptide vaccinations as well as the utilization of live attenuated vaccines and nucleic acid vaccinations. Furthermore, the invention also covers immunogenic analogues of these cancer-specific antigens, along with nucleic acid molecules encoding them, vectors, and transformed cells, alongside methods for identifying immunogenic analogues of weak or non-immunogenic antigens.
Career Highlights
Mouritsen has an impressive track record working with notable companies in the biotech sector. His experience includes roles at Pharmexa A/S and Bn Immunotherapeutics, Inc., through which he has further developed his expertise in immunotherapy and vaccine development. His contributions in these companies have laid the groundwork for significant advancements in therapeutic approaches to cancer and other diseases.
Collaborations
Throughout his career, Søren Mouritsen has collaborated with distinguished professionals in the field, including Iben Dalum and Lucilla Steinaa. These partnerships have fostered a collaborative environment that promotes the sharing of ideas and innovation in therapeutic modalities.
Conclusion
Søren Mouritsen stands out as a key innovator in therapeutic vaccination, driving advances that could change the landscape of treating diseases, particularly cancer. His patented methods reflect a deep understanding of immunology and a commitment to enhancing patient outcomes through innovative therapeutic strategies.